IL195060A0 - Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof - Google Patents

Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof

Info

Publication number
IL195060A0
IL195060A0 IL195060A IL19506008A IL195060A0 IL 195060 A0 IL195060 A0 IL 195060A0 IL 195060 A IL195060 A IL 195060A IL 19506008 A IL19506008 A IL 19506008A IL 195060 A0 IL195060 A0 IL 195060A0
Authority
IL
Israel
Prior art keywords
manufacturing procedure
moisture sensitive
stable formulation
sensitive drug
drug
Prior art date
Application number
IL195060A
Original Assignee
Teva Pharma
Fox Michael
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma, Fox Michael filed Critical Teva Pharma
Publication of IL195060A0 publication Critical patent/IL195060A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
IL195060A 2006-06-02 2008-11-02 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof IL195060A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/021586 WO2007142628A1 (en) 2006-06-02 2006-06-02 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof

Publications (1)

Publication Number Publication Date
IL195060A0 true IL195060A0 (en) 2011-08-01

Family

ID=37607178

Family Applications (1)

Application Number Title Priority Date Filing Date
IL195060A IL195060A0 (en) 2006-06-02 2008-11-02 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof

Country Status (8)

Country Link
JP (1) JP2009538905A (en)
CN (1) CN101460191A (en)
BR (1) BRPI0621739A2 (en)
CA (1) CA2652620A1 (en)
IL (1) IL195060A0 (en)
MX (1) MX2008015343A (en)
NO (1) NO20085423L (en)
WO (1) WO2007142628A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008020701A1 (en) 2008-04-24 2009-10-29 Bayer Technology Services Gmbh Formulation with reduced hygroscopicity
EP2814465B1 (en) * 2012-02-17 2019-07-03 Egis Gyógyszergyár Zrt. Pharmaceutical formulation having improved stability
FR2991179B1 (en) 2012-06-01 2016-11-11 Ceva Sante Animale ORAL VETERINARY COMPOSITIONS APPENDED

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739690A1 (en) * 1987-11-24 1989-06-08 Hoechst Ag STABILIZED MEDICINAL PRODUCTS, METHOD FOR THEIR PRODUCTION AND STABLE MEDICAL PREPARATIONS
DE19952030A1 (en) * 1999-10-28 2001-05-03 Basf Ag Process for the production of highly reactive polyisobutenes
AU2003217916A1 (en) * 2002-03-08 2003-09-22 Teva Pharmeceuticals Usa, Inc. Stable formulations of angiotensin converting enzyme (ace) inhibitors
US6869963B2 (en) * 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor
PE20060003A1 (en) * 2004-03-12 2006-03-01 Smithkline Beecham Plc POLYMERIC PHARMACEUTICAL FORMULATION FOR INJECTION MOLDING

Also Published As

Publication number Publication date
BRPI0621739A2 (en) 2011-12-20
JP2009538905A (en) 2009-11-12
CN101460191A (en) 2009-06-17
NO20085423L (en) 2009-02-25
MX2008015343A (en) 2008-12-16
CA2652620A1 (en) 2007-12-13
WO2007142628A1 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
EP2056106A4 (en) Sugar chain-capturing substance and use thereof
HK1109861A1 (en) Dry granulated composition comprising emtricitabine and tenofovir df
EP2084519A4 (en) Advanced drug development and manufacturing
EP1806152A4 (en) Drug for external use and adhesive patch
DK2073795T3 (en) Abuse-safe drug formulation
EP1909772A4 (en) Transdermal drug delivery formulation
EP1882042A4 (en) Combined drug delivery and analyte sensor apparatus
EP2191436A4 (en) Wireless physiological sensor patches and systems
IL194688A0 (en) Rapid acting and long acting insulin combination formulations
EP2042138A4 (en) Patch and patch preparation
ZA201101477B (en) Co-crystals and pharmaceutical formulations comprising the same
EP2116234A4 (en) Pharmaceutical composition for external application and adhesive skin patch
IL184735A0 (en) Pharmaceutical formulations and methods of use
IL199265A (en) Substituted oxindole derivatives and use thereof in the preparation of medicaments
HK1244819A1 (en) Foxm1 peptide and medicinal agent comprising the same
IL197877A (en) Uses of aminomethyl-4-imidazole derivatives for the preparation of medicaments and medicaments comprising them
IL198046A (en) Metastin derivatives and medicaments comprising the same
IL194751A0 (en) Drugs and uses
IL188744A0 (en) High drug load formulations and dosage forms
GB0516069D0 (en) Pharmaceutical and use thereof
GB2443336B (en) Spiruchostatin analogues and their medicinal use
GB0604966D0 (en) Medicaments and proteins
IL193211A (en) Indazole-heteroaryl derivatives and pharmaceutical compositions comprising them
IL192206A0 (en) Topical mecamylamine formulations for ocular administration and uses thereof
IL197273A0 (en) Pharmaceutical and sunscreen compositions comprising caspase-14